Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Amortization of Deferred Charges: 2019-2025

Historic Amortization of Deferred Charges for Wave Life Sciences (WVE) over the last 7 years, with Sep 2025 value amounting to $1.4 million.

  • Wave Life Sciences' Amortization of Deferred Charges rose 13.55% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 13.51%. This contributed to the annual value of $4.8 million for FY2024, which is 13.34% up from last year.
  • As of Q3 2025, Wave Life Sciences' Amortization of Deferred Charges stood at $1.4 million, which was up 3.23% from $1.3 million recorded in Q2 2025.
  • Wave Life Sciences' Amortization of Deferred Charges' 5-year high stood at $1.4 million during Q3 2025, with a 5-year trough of $512,000 in Q1 2021.
  • For the 3-year period, Wave Life Sciences' Amortization of Deferred Charges averaged around $1.2 million, with its median value being $1.2 million (2024).
  • Data for Wave Life Sciences' Amortization of Deferred Charges shows a peak YoY spiked of 75.27% (in 2022) over the last 5 years.
  • Over the past 5 years, Wave Life Sciences' Amortization of Deferred Charges (Quarterly) stood at $759,000 in 2021, then rose by 29.51% to $983,000 in 2022, then grew by 12.00% to $1.1 million in 2023, then climbed by 13.44% to $1.2 million in 2024, then grew by 13.55% to $1.4 million in 2025.
  • Its Amortization of Deferred Charges was $1.4 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.3 million in Q1 2025.